tradingkey.logo
tradingkey.logo
Search

Grace Therapeutics, Inc

GRCE
Add to Watchlist
2.160USD
+0.000+0.00%
Market hours ETQuotes delayed by 15 min
35.15MMarket Cap
LossP/E TTM

GRCE Income Statement

You can find the annual or quarterly income statement of Grace Therapeutics, Inc here for insights into the performance and operational efficiency of Grace Therapeutics, Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2027Q1
FY2026Q4
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q4
FY2018Q3
FY2018Q2
FY2018Q1
FY2017Q4
FY2017Q3
FY2017Q2
FY2017Q1
FY2016Q4
FY2016Q3
FY2016Q2
FY2016Q1
FY2015Q4
FY2015Q3
FY2015Q2
FY2015Q1
FY2014Q4
FY2014Q3
FY2014Q2
FY2014Q1
FY2013Q4
FY2013Q3
FY2013Q2
FY2013Q1
FY2012Q4
FY2012Q3
FY2012Q2
FY2012Q1
Total revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
----
----
--81.00K
----
----
--0.00
----
----
----
----
----
----
----
----
----
----
-75.32%948.57
-48.63%2.81K
-46.62%2.22K
-90.08%14.71K
-85.09%3.84K
-21.35%5.48K
-91.84%4.16K
-19.51%148.29K
-5.39%25.78K
-97.28%6.97K
714.86%50.99K
275.34%184.23K
-93.66%27.25K
9.30%256.53K
-54.23%6.26K
376.95%49.08K
--429.64K
591.40%234.69K
-84.06%13.67K
--10.29K
--0.00
--33.94K
--85.79K
Revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
----
----
--81.00K
----
----
--0.00
----
----
----
----
----
----
----
----
----
----
-75.32%948.57
-48.63%2.81K
-46.62%2.22K
-90.08%14.71K
-85.09%3.84K
-21.35%5.48K
-91.84%4.16K
-19.51%148.29K
-5.39%25.78K
-97.28%6.97K
714.86%50.99K
275.34%184.23K
-93.66%27.25K
9.30%256.53K
-54.23%6.26K
376.95%49.08K
--429.64K
591.40%234.69K
-84.06%13.67K
--10.29K
--0.00
--33.94K
--85.79K
Cost of revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
----
----
--36.00K
----
----
--0.00
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-64.66%53.33K
-91.28%1.81K
-56.17%1.83K
-90.94%2.14K
33.71%150.91K
33.97%20.77K
-97.14%4.17K
1170.50%23.67K
-73.49%112.87K
-96.24%15.50K
19.17%145.84K
-59.18%1.86K
8386.88%425.76K
150.29%411.98K
--122.37K
--4.57K
--5.02K
--164.60K
--0.00
--0.00
Operating expenses
-22.85%2.38M
-5.44%3.01M
-33.88%2.45M
-47.65%2.53M
-37.74%3.09M
-2.45%3.18M
21.72%3.70M
133.04%4.83M
67.90%4.96M
-21.66%3.26M
-28.32%3.04M
-59.41%2.07M
-37.51%2.96M
-5.41%4.17M
0.47%4.25M
43.17%5.11M
50.40%4.73M
--4.40M
106.60%4.22M
29.99%3.57M
-23.68%3.15M
-66.73%2.04M
-56.13%2.74M
-48.53%4.12M
-24.15%6.15M
-21.72%6.25M
4.13%8.01M
99.77%8.10M
128.45%7.99M
269.30%7.69M
134.93%5.82M
114.00%4.06M
84.90%3.50M
-8.62%2.08M
82.06%2.48M
-5.16%1.90M
11.53%1.89M
7.91%2.28M
-48.58%1.36M
-25.39%2.00M
-46.98%1.70M
-23.30%2.11M
17.35%2.65M
-16.65%2.68M
-5.83%3.20M
41.63%2.75M
10.13%2.26M
54.77%3.21M
73.58%3.40M
18.89%1.94M
32.47%2.05M
-4.81%2.08M
8.12%1.96M
43.51%1.63M
--1.55M
--2.18M
--1.81M
--1.14M
R&D expenses
-27.02%697.00K
-74.30%420.00K
-78.94%462.00K
-80.91%568.00K
-64.73%955.00K
-2.74%1.63M
52.04%2.19M
582.57%2.98M
154.75%2.71M
4.87%1.68M
-43.61%1.44M
-86.45%436.00K
-60.02%1.06M
-41.08%1.60M
14.55%2.56M
350.56%3.22M
466.95%2.66M
--2.72M
225.66%2.23M
-22.56%714.00K
-63.56%469.00K
-80.04%686.00K
-72.87%922.00K
-77.41%1.29M
-52.46%3.44M
-51.36%3.40M
-17.28%5.70M
154.00%7.23M
226.63%6.99M
604.00%6.89M
423.14%4.26M
254.95%2.85M
73.71%2.14M
-28.83%978.13K
39.37%814.45K
-24.21%801.88K
41.02%1.23M
26.75%1.37M
-59.89%584.37K
-32.40%1.06M
-47.57%873.29K
-2.20%1.08M
121.61%1.46M
27.25%1.57M
13.28%1.67M
45.33%1.11M
-28.62%657.41K
57.64%1.23M
95.34%1.47M
36.13%762.79K
135.92%920.96K
-41.90%780.25K
-19.07%752.73K
17.54%560.36K
--390.37K
--1.34M
--930.15K
--476.75K
Depreciation, depletion, and amortization
0.00%2.00K
0.00%2.00K
200.00%3.00K
-50.00%1.00K
100.00%2.00K
-95.00%2.00K
0.00%1.00K
0.00%2.00K
-85.71%1.00K
150.00%40.00K
--1.00K
--2.00K
-95.81%7.00K
--16.00K
----
----
--167.00K
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-32.25%376.00K
-3.86%548.00K
8.78%595.00K
5.23%555.00K
7.55%570.00K
3.50%546.98K
-0.86%527.44K
6.83%529.99K
-21.78%527.65K
12.86%528.47K
12.36%532.04K
5.89%496.13K
-60.40%674.61K
2.85%468.26K
1.74%473.49K
-1.34%468.54K
250.50%1.70M
-12.87%455.27K
-13.92%465.40K
-10.34%474.88K
21.28%486.01K
-19.00%522.55K
11.63%540.69K
226.14%529.64K
3.17%400.73K
282.65%645.09K
194.55%484.35K
-2.43%162.40K
135.42%388.43K
2.42%168.59K
-4.30%164.44K
-3.58%166.45K
--164.99K
--164.60K
--171.82K
--172.62K
Other operating expenses
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
100.00%0.00
-93.65%4.00K
107.89%15.00K
107.89%31.00K
-109.09%-115.00K
148.84%63.00K
---190.00K
---393.00K
-587.50%-55.00K
-32.99%-129.00K
100.00%0.00
93.33%-8.00K
---97.00K
-1.33%-76.00K
---120.00K
--0.00
---75.00K
----
----
----
----
----
----
----
--5.88K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
-415.11%-15.92M
5.44%-3.01M
33.88%-2.45M
47.65%-2.53M
37.74%-3.09M
2.45%-3.18M
-21.72%-3.70M
-133.04%-4.83M
-67.90%-4.96M
21.66%-3.26M
28.32%-3.04M
59.41%-2.07M
37.51%-2.96M
5.41%-4.17M
-0.47%-4.25M
-43.17%-5.11M
-50.40%-4.73M
---4.40M
-115.12%-4.22M
-29.99%-3.57M
23.68%-3.15M
68.04%-1.96M
56.13%-2.74M
48.53%-4.12M
24.15%-6.15M
21.72%-6.25M
-4.13%-8.01M
-99.77%-8.10M
-128.45%-7.99M
-269.30%-7.69M
-134.93%-5.82M
-114.11%-4.06M
-85.18%-3.50M
8.53%-2.08M
-84.05%-2.48M
5.03%-1.89M
-11.72%-1.89M
-8.02%-2.28M
46.12%-1.35M
24.81%-1.99M
47.04%-1.69M
22.01%-2.11M
-20.63%-2.50M
16.74%-2.65M
-1.64%-3.19M
-39.45%-2.70M
-3.62%-2.07M
-93.49%-3.19M
-82.34%-3.14M
-19.51%-1.94M
-30.16%-2.00M
24.51%-1.65M
3.03%-1.72M
-53.90%-1.62M
---1.54M
---2.18M
---1.78M
---1.05M
Net non-operating interest income (expenses)
Non-operating interest income
-31.22%141.00K
-17.37%138.00K
23.19%170.00K
0.00%172.00K
-12.77%205.00K
-32.93%167.00K
-56.33%138.00K
-18.87%172.00K
75.37%235.00K
33.16%249.00K
393.75%316.00K
--212.00K
--134.00K
--187.00K
60.00%64.00K
-100.00%0.00
-100.00%0.00
----
5.26%40.00K
-6.67%14.00K
456.00%139.00K
-17.39%38.00K
-88.00%15.00K
-75.73%25.00K
-70.19%46.00K
298.27%125.00K
259.27%103.00K
2077.34%154.33K
181.05%31.39K
140.89%28.67K
257.86%26.11K
0.52%7.09K
-69.33%11.17K
-73.86%11.90K
-75.78%7.29K
132.81%7.05K
548.83%36.41K
164.15%45.54K
-94.79%30.12K
-99.94%3.03K
-76.92%5.61K
-99.59%17.24K
8458.12%577.96K
69181.95%4.68M
228.62%24.32K
42243.26%4.24M
-43.56%6.75K
-45.24%6.75K
-53.06%7.40K
38.95%10.01K
-6.05%11.96K
-15.79%12.34K
130.96%15.76K
-20.42%7.21K
--12.74K
--14.65K
--6.82K
--9.06K
Non-operating interest expense
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-23.85%53.00K
-0.61%70.00K
-4.98%67.00K
-3.94%69.60K
73.12%70.43K
82.30%70.51K
142.20%71.20K
--72.46K
--40.68K
--38.68K
--29.40K
----
----
----
----
----
----
----
-99.90%1.01K
-99.84%844.66
46869.44%295.17K
--642.06
--988.16K
75800.35%530.28K
51.66%628.42
----
----
-30.91%698.66
-90.76%414.37
118.57%869.98
--3.15K
--1.01K
--4.49K
--398.03
Gains from sale of securities
-240.00%-14.00K
0.00%-6.00K
125.00%4.00K
-161.54%-8.00K
225.00%10.00K
57.14%-6.00K
-633.33%-16.00K
200.00%13.00K
-200.00%-8.00K
-566.67%-14.00K
-80.00%3.00K
-8.33%-13.00K
110.26%8.00K
100.64%3.00K
108.72%15.00K
-101.09%-12.00K
89.67%-78.00K
---471.00K
12.24%-172.00K
813.64%1.10M
-1137.70%-755.00K
-122.73%-196.00K
-862.50%-154.00K
-208.93%-61.00K
-143.24%-88.00K
-113.84%-16.00K
110.68%56.00K
122.73%203.51K
232.95%115.59K
-815.88%-524.57K
368.72%56.96K
-1199.21%-895.48K
-1561.68%-86.94K
74.07%-57.27K
98.49%-21.20K
29.04%81.47K
-99.14%5.95K
-216.50%-220.88K
---1.41M
-90.55%63.13K
1978.70%695.51K
77.07%-69.79K
----
29281.99%668.34K
159.72%33.46K
-13907.20%-304.34K
2411.03%702.63K
-36.41%2.27K
149.63%12.88K
-94.04%2.20K
2225.97%27.98K
145.41%3.58K
-19154.85%-25.96K
379.14%36.99K
---1.32K
---7.88K
---134.80
---13.25K
Special income (expenses)
-2678.85%-13.53M
-100.00%0.00
96.60%-40.00K
294.20%1.43M
-134.91%-487.00K
357.06%2.64M
-1042.40%-1.18M
119.62%362.00K
193.12%1.40M
96.97%-1.03M
--125.00K
---1.84M
-15080.00%-1.50M
-11832.87%-33.91M
-100.00%0.00
-100.00%0.00
-98.44%10.00K
--289.00K
152.73%579.00K
205.27%3.44M
226.33%643.00K
81.33%-1.10M
78.16%-3.26M
45.39%-509.00K
-235.95%-5.88M
-57.53%-14.94M
-137.20%-932.00K
1787.84%4.33M
-49648.48%-9.49M
2413.30%2.51M
-457.21%-627.32K
15759.26%229.19K
-62.12%19.14K
295.71%99.67K
-108.39%-112.58K
-100.54%-1.46K
172.69%50.54K
-98.17%25.19K
--1.34M
--268.69K
--18.53K
--1.38M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
----
----
----
----
----
----
----
----
----
----
----
----
----
-151.02%-75.00K
--3.00K
--35.00K
--32.00K
--147.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income before tax
-369.66%-15.79M
-653.40%-2.88M
51.37%-2.31M
78.10%-938.00K
-0.63%-3.36M
90.58%-382.00K
-83.15%-4.76M
-15.19%-4.28M
22.52%-3.34M
89.32%-4.05M
37.57%-2.60M
26.85%-3.72M
9.53%-4.31M
-733.88%-37.96M
-10.19%-4.16M
-618.25%-5.08M
-52.85%-4.77M
---4.55M
-17.33%-3.78M
115.96%981.00K
33.18%-3.12M
73.44%-3.22M
70.95%-6.15M
47.25%-4.67M
-247.60%-12.12M
-21.60%-21.16M
-53.84%-8.85M
27.15%-3.49M
-383.98%-17.40M
-178.27%-5.75M
-144.39%-6.44M
-164.91%-4.79M
-100.18%-3.60M
14.83%-2.07M
-90.61%-2.63M
-8.89%-1.81M
-84.95%-1.80M
-211.07%-2.43M
28.12%-1.38M
-161.59%-1.66M
71.69%-971.02K
-163.23%-779.96K
18.21%-1.92M
172.69%2.69M
-9.89%-3.43M
164.08%1.23M
-19.96%-2.35M
-127.25%-3.71M
-80.09%-3.12M
-22.02%-1.93M
-28.25%-1.96M
25.01%-1.63M
2.31%-1.73M
-49.14%-1.58M
---1.53M
---2.18M
---1.77M
---1.06M
Income tax
--0.00
-66.99%-1.70M
100.00%0.00
100.00%0.00
100.00%0.00
-14.51%-1.02M
-190.87%-605.00K
-91.03%-852.00K
-150.52%-724.00K
89.98%-889.00K
24.09%-208.00K
-187.74%-446.00K
-19.42%-289.00K
-1268.98%-8.87M
---274.00K
---155.00K
---242.00K
---648.00K
----
----
----
----
----
----
----
----
----
----
----
----
100.00%0.00
----
----
----
---97.23K
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
----
--0.00
--0.00
--0.00
----
--0.00
--0.00
--0.00
--0.00
Income after tax
-369.66%-15.79M
-285.22%-1.18M
44.28%-2.31M
72.67%-938.00K
-28.47%-3.36M
120.09%636.00K
-73.78%-4.16M
-4.86%-3.43M
34.95%-2.62M
89.12%-3.17M
38.52%-2.39M
33.60%-3.27M
11.07%-4.02M
-645.06%-29.09M
-2.94%-3.89M
-602.45%-4.93M
-45.09%-4.52M
---3.90M
-17.33%-3.78M
115.96%981.00K
33.18%-3.12M
73.44%-3.22M
70.95%-6.15M
47.25%-4.67M
-247.60%-12.12M
-21.60%-21.16M
-53.84%-8.85M
27.15%-3.49M
-383.98%-17.40M
-178.27%-5.75M
-153.76%-6.44M
-164.91%-4.79M
-100.18%-3.60M
14.83%-2.07M
-83.58%-2.54M
-8.89%-1.81M
-84.95%-1.80M
-211.07%-2.43M
28.12%-1.38M
-161.59%-1.66M
71.69%-971.02K
-163.23%-779.96K
18.21%-1.92M
172.69%2.69M
-9.89%-3.43M
164.08%1.23M
-19.96%-2.35M
-127.25%-3.71M
-80.09%-3.12M
-22.02%-1.93M
-28.25%-1.96M
25.01%-1.63M
2.31%-1.73M
-49.14%-1.58M
---1.53M
---2.18M
---1.77M
---1.06M
Net income from continuous operations
-369.66%-15.79M
-285.22%-1.18M
44.28%-2.31M
72.67%-938.00K
-28.47%-3.36M
120.09%636.00K
-73.78%-4.16M
-4.86%-3.43M
34.95%-2.62M
89.12%-3.17M
38.52%-2.39M
33.60%-3.27M
11.07%-4.02M
-645.06%-29.09M
-2.94%-3.89M
-602.45%-4.93M
-45.09%-4.52M
---3.90M
-17.33%-3.78M
115.96%981.00K
33.18%-3.12M
73.44%-3.22M
70.95%-6.15M
47.25%-4.67M
-247.60%-12.12M
-21.60%-21.16M
-53.84%-8.85M
27.15%-3.49M
-383.98%-17.40M
-178.27%-5.75M
-153.76%-6.44M
-164.91%-4.79M
-100.18%-3.60M
14.83%-2.07M
-83.58%-2.54M
-8.89%-1.81M
-84.95%-1.80M
-211.07%-2.43M
28.12%-1.38M
-161.59%-1.66M
71.69%-971.02K
-163.23%-779.96K
18.21%-1.92M
172.69%2.69M
-9.89%-3.43M
164.08%1.23M
-19.96%-2.35M
-127.25%-3.71M
-80.09%-3.12M
-22.02%-1.93M
-28.22%-1.96M
25.01%-1.63M
2.31%-1.73M
-49.14%-1.58M
---1.53M
---2.18M
---1.77M
---1.06M
Other net gains and losses
----
---1.70M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
---389.32
----
----
----
Net income attributable to controlling interests
-369.66%-15.79M
-285.22%-1.18M
44.28%-2.31M
72.67%-938.00K
-28.47%-3.36M
120.09%636.00K
-73.78%-4.16M
-4.86%-3.43M
34.95%-2.62M
89.12%-3.17M
38.52%-2.39M
33.60%-3.27M
11.07%-4.02M
-645.06%-29.09M
-2.94%-3.89M
-602.45%-4.93M
-45.09%-4.52M
---3.90M
-17.33%-3.78M
115.96%981.00K
33.18%-3.12M
73.44%-3.22M
70.95%-6.15M
47.25%-4.67M
-247.60%-12.12M
-21.60%-21.16M
-53.84%-8.85M
27.15%-3.49M
-383.98%-17.40M
-178.27%-5.75M
-153.76%-6.44M
-164.91%-4.79M
-100.18%-3.60M
14.83%-2.07M
-83.58%-2.54M
-8.89%-1.81M
-84.95%-1.80M
-211.07%-2.43M
28.12%-1.38M
-161.59%-1.66M
71.69%-971.02K
-163.23%-779.96K
18.21%-1.92M
172.69%2.69M
-9.89%-3.43M
164.08%1.23M
-19.96%-2.35M
-127.25%-3.71M
-80.09%-3.12M
-22.02%-1.93M
-28.22%-1.96M
25.01%-1.63M
2.31%-1.73M
-49.14%-1.58M
---1.53M
---2.18M
---1.77M
---1.06M
Net income attributable to common shareholders
-369.66%-15.79M
-285.22%-1.18M
44.28%-2.31M
72.67%-938.00K
-28.47%-3.36M
120.09%636.00K
-73.78%-4.16M
-4.86%-3.43M
34.95%-2.62M
89.12%-3.17M
38.52%-2.39M
33.60%-3.27M
11.07%-4.02M
-645.06%-29.09M
-2.94%-3.89M
-602.45%-4.93M
-45.09%-4.52M
---3.90M
-17.33%-3.78M
115.96%981.00K
33.18%-3.12M
73.44%-3.22M
70.95%-6.15M
47.25%-4.67M
-247.60%-12.12M
-21.60%-21.16M
-53.84%-8.85M
27.15%-3.49M
-383.98%-17.40M
-178.27%-5.75M
-153.76%-6.44M
-164.91%-4.79M
-100.18%-3.60M
14.83%-2.07M
-83.58%-2.54M
-8.89%-1.81M
-84.95%-1.80M
-211.07%-2.43M
28.12%-1.38M
-161.59%-1.66M
71.69%-971.02K
-163.23%-779.96K
18.21%-1.92M
172.69%2.69M
-9.89%-3.43M
164.08%1.23M
-19.96%-2.35M
-127.25%-3.71M
-80.09%-3.12M
-22.02%-1.93M
-28.22%-1.96M
25.01%-1.63M
2.31%-1.73M
-49.14%-1.58M
---1.53M
---2.18M
---1.77M
---1.06M
Basic earnings per share
-333.07%-0.91
-248.45%-0.07
62.14%-0.14
80.25%-0.06
11.83%-0.21
113.65%0.05
-73.78%-0.36
31.17%-0.30
55.74%-0.24
91.32%-0.34
60.27%-0.21
34.71%-0.43
11.65%-0.54
-510.54%-3.88
-2.19%-0.52
-469.75%-0.66
14.72%-0.61
---0.64
63.42%-0.51
105.79%0.18
70.92%-0.72
79.14%-1.40
74.63%-3.10
54.26%-2.47
-183.75%-6.71
46.36%-12.22
37.73%-5.40
84.33%-2.36
-94.44%-22.79
-28.61%-8.67
-22.91%-12.23
-86.27%-15.08
-45.63%-11.72
37.98%-6.74
-60.08%-9.95
-8.38%-8.10
-84.04%-8.05
-208.99%-10.87
28.38%-6.22
-161.38%-7.47
71.79%-4.37
-162.92%-3.52
20.42%-8.68
157.43%12.17
20.39%-15.50
144.28%5.59
15.51%-10.91
-96.97%-21.20
-70.13%-19.47
-21.19%-12.63
-25.71%-12.91
28.14%-10.76
13.34%-11.44
-29.77%-10.42
---10.27
---14.98
---13.20
---8.03
Diluted earnings per share
-333.07%-0.91
-248.45%-0.07
62.14%-0.14
80.25%-0.06
11.83%-0.21
113.65%0.05
-73.78%-0.36
31.17%-0.30
55.74%-0.24
91.32%-0.34
60.27%-0.21
34.71%-0.43
11.65%-0.54
-510.54%-3.88
-2.19%-0.52
-469.75%-0.66
14.72%-0.61
---0.64
63.42%-0.51
105.79%0.18
70.92%-0.72
79.14%-1.40
74.63%-3.10
54.26%-2.47
-183.75%-6.71
46.36%-12.22
37.73%-5.40
84.33%-2.36
-94.44%-22.79
-28.61%-8.67
-22.91%-12.23
-86.27%-15.08
-45.63%-11.72
37.98%-6.74
-60.08%-9.95
-8.38%-8.10
-84.04%-8.05
-208.99%-10.87
28.38%-6.22
-161.87%-7.47
71.79%-4.37
-163.46%-3.52
20.42%-8.68
156.97%12.08
20.39%-15.50
143.90%5.54
15.51%-10.91
-96.97%-21.20
-70.13%-19.47
-21.19%-12.63
-25.71%-12.91
28.14%-10.76
13.34%-11.44
-29.77%-10.42
---10.27
---14.98
---13.20
---8.03
Dividend per share
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read Grace Therapeutics, Inc's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing GRCE stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Grace Therapeutics, Inc's net income for the year?

Grace Therapeutics, Inc posted -7.79M in net income for fiscal year 2025.

How much net income did Grace Therapeutics, Inc post in the last quarter?

Grace Therapeutics, Inc reported -15.79M in net income for the latest quarter。

What was Grace Therapeutics, Inc's annual operating profit?

Grace Therapeutics, Inc's operating income was -16.68M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.